LEGAL ISSUES V. POLICY ISSUES
Among the major issues in federal health reform, there are recurring questions that are policybased and those that are legally-based. Many times questions of policy and of law overlap and cannot be considered in isolation. However, for the purpose of this project, we draw the distinction between law and policy based on the presence of clear legal permission or prohibition.
Under this distinction, policy issues include larger-scale questions such as what basic model of health reform to use, as well as more technical questions such as what threshold to use for poverty level subsidies and cost-sharing for preventive services. In contrast, legal issues are those involving constitutional, statutory, or regulatory questions such as whether the Constitution allows a certain congressional action or whether particular laws run parallel or conflict.
Based on this dividing line of clear permission or prohibition, policy questions can be framed as those beginning with, "Should we…?", and legal questions can be framed as those beginning with, "Can we…?" The focus of this paper will be the latter, broken into three particular categories: 1) "Under the Constitution, can we ever…?"; 2) "Under current statutes and regulations, can we now…?"; 3) " Under the current regulatory scheme, how do we…?" This final set of questions tends to be mixed questions of policy, law, and good legislative drafting. 
PURPOSE AND LAYOUT OF THE PROJECT
This project is an effort to frame and study legal challenges and solutions in advance of the heat of political debate. This effort is undertaken with the optimistic view that all legal problems addressed are either soluble or avoidable. Rather than setting up roadblocks, this project is a constructive activity, attempting to pave the road towards improved health care for the nation. Consequently, it does not attempt to create consensus solutions for the identified problems nor is it an attempt to provide a unified field theory of how to provide health insurance in America. Furthermore, this project does not attempt to choose among the currently competing proposals or make recommendations among them. Instead, it is a comprehensive project written to provide policy makers, attorneys, and other key stakeholders with a concise analysis of the complex legal issues relating to health reform and a clear articulation of the range of solutions available for resolving those questions.
LEGAL ISSUES
Based on surveys of current health policy meetings and agendas, popular and professional press, and current health reform proposals, our team formulated a list of legal issues relating to federal health reform. After much research, discussion, and expert advice and review, our initial list of over 50 legal issues was narrowed to ten. An initial framing paper was drafted which identified these ten legal issues and briefly outlined the main components of each. In May of 2008, a bipartisan consultation session was convened to provide concrete feedback on the choice and framing of the legal issues. The attendees of the consultation session included congressional staff, executive branch officials, advocates, attorneys, employers, and representatives of a wide range of interests affected by health reform. Feedback and analysis from this session further narrowed the ten issues to eight key legal issues which warranted in depth analysis of the current law.
These eight pertinent issues are truly legal in nature and must be addressed in any significant reform proposal to avoid needless debate or pitfalls as policy decisions are made. There are multiple other legal issues that will arise as the discussion evolves and, if a federal policy is adopted, the system changes. In this project, however, we have targeted the issues essential for an immediate discussion of federal health reform. 
Introduction
Presidential power has provoked increasingly vigorous debate since the turn of this century. In recent years, scholars and lawyers have been grappling with how Congress's dictates may limit the President's Commander-in-Chief power to detain enemy combatants at Guantanamo Bay, to fight wars abroad, and to conduct intelligence activities at home. But policymakers have not yet explored the many possibilities for invoking the President's "Take Care" power to change health care policy. Policymakers in the Obama Administration are not the only ones who need to understand the scope of executive authority. As Congress begins to tackle its health care agenda, policymakers on the Hill should know how proposed legislation would affect the President's power. More specific statutes would limit the executive branch's ability to make policy decisions. On the other hand, health reform legislation that provides only the skeleton of a new program would provide greater opportunities for President Obama and his agencies to fill out the details. There is ample precedent for this approach. For example, Congress opened the door for President Roosevelt's groundbreaking New Deal policies by authorizing the creation of new programs while providing minimal guidance on key details of administrative implementation. 1 In addition, legislators should keep in mind that how they draft legislation can affect the level of deference that courts provide to agency interpretations of statutes. Fewer statutory details mean greater judicial deference to the executive in the event of a challenge.
Part I provides a user's manual on executive authority. With an eye toward the non-legal audience, it describes the various administrative tools at the President's disposal. Part II moves the discussion from the conceptual to the specific. It suggests ways that President Obama could use administrative tools to reform health care. While this paper focuses on the "how, Part III assesses the potential legal, budgetary, and legislative constraints on a President's Article II powers to interpret the law. It explains how Congress and the courts can limit the President's latitude to make policy changes through the administrative process. More broadly, it highlights the continuing struggle between the three branches to influence health policy. The paper concludes with a discussion of why congressional lawmakers should consider how their proposed legislation would impact executive authority as they craft health reform proposals.
I. Overview of Executive Authority
Decreasing health care costs, expanding coverage, modernizing the delivery of care-there are an endless number of policy proposals for reforming our health care system. Policymakers in Congress and in the Obama Administration are crafting the key reform proposals that will shape their agenda. It is important to remember that the process through which these policies are created can be just as critical to the overall success as getting the substance of the policy right.
Presidents have a wide array of administrative options at their disposal. This section briefly describes these various tools and explains how executive authority has evolved during the past thirty years.
Administrative law scholars deem the various tools at a President's disposal as "presidential directives." There are numerous types of directives, but all share the general purpose of "establishing new policy, decreeing the commencement or cessation of some action, or ordaining that notice be given to some declaration." 2 Directives can be divided into three categories: executive orders and proclamations, regulatory actions, and sub-regulatory guidance. In addition, Presidents use signing statements to communicate their disagreement with statutory provisions they believe encroach on their executive authority. As explained in Part III, courts scrutinize each type of administrative tool to varying degrees when reviewing the legality of administrative action.
A. Executive Orders and Proclamations
Perhaps the most well-known directive is the executive order, which dates back to George Washington's Administration. Presidents employ executive orders to direct the actions of agency employees and instruct subordinates to create or implement particular policies. 3 The sources of authority for executive orders are twofold: one is constitutional, including the Article II requirement that the President "take Care that the Laws be faithfully executed," 4 and the other is any statutory language that delegates specific power to the executive branch to implement and flesh out the details of a duly enacted program. Executive orders can make significant policy changes, particularly during wartime or when a President relies on his constitutional powers to deal with an emergency situation. 5 For example, President Abraham Lincoln's Emancipation Proclamation consisted of two executive orders freeing slaves in most of the confederate states. 6 Proclamations, another type of presidential directive, differ from executive orders in that they are generally aimed at the public rather than agencies. Modern-day proclamations generally encourage activity or recognize interests rather than direct specific action. 7 Otherwise, most of the differences between proclamations and executive orders are formal rather than substantive. Like executive orders, Presidents must publish all proclamations pursuant to the requirements of the Federal Register Act of 1935.
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B. Regulatory Actions
Regulations-also known as rules-are a common administrative tool invoked by agencies. The Administrative Procedure Act ("APA") defines them as "the whole or part of an agency statement of general or particular applicability and future effect designed to implement, interpret, or prescribe law or policy." 10 Often, Congress will delegate authority to agencies to flesh out the details of a new program by promulgating regulations. These rules not only must stay within the bounds of the statutory language, they also must be consistent with the Constitution (like any other directive). In addition, the APA requires agencies to notify the public before issuing a rule so that interested parties can comment on the proposal. 11 There is a large body of literature analyzing the various permutations of the regulatory process, as well as the legal weight afforded to regulations. This Paper touches on these issues in Part III.
C. Sub-regulatory Guidance
Sub-regulatory guidance includes letters, memoranda, determinations, agreements, findings, and other types of directives. 12 Agencies often use sub-regulatory guidance to implement demonstration projects authorized by Congress, as explained in Part II. There is an open debate about whether this includes forms of communication typically associated with public relationsfor example, press releases and web pages. Presidents and their agencies have employed subregulatory guidance to direct and govern the activities of federal employees, and, much like executive orders and proclamations, they may have the force of law if published in the Federal Register and issued pursuant to a valid source of executive authority. 13 The only difference between sub-regulatory guidance and executive orders and proclamations is that there are no mandatory publication requirements for sub-regulatory guidance unless 1) Congress has required it or 2) the directives have "general applicability and legal effect."
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D. Signing Statements
Although not a presidential directive (partly because it does not establish policy), a signing statement is another tool in the executive's arsenal. When presidents sign bills into law, they sometimes issue official pronouncements "to forward the President's interpretation of the statutory language; to assert constitutional objections to the provisions contained therein; and . . . to announce that the provisions of the law will be administered in a manner that comports with the Administration's conception of the President's constitutional prerogatives." 15 Often, Presidents use signing statements to communicate disagreement about statutory provisions that they believe encroach on their executive authority. Even though Presidents technically began using signing statements more than two hundred years ago, President Ronald Reagan was the first to invoke them in voicing substantial constitutional concerns regarding statutory language. 16 It is unclear whether signing statements have the force of law. Many scholars argue that if a President's application of the statute conflicts with the wishes of Congress, signing statements do not provide an authoritative source of power to rectify or even assuage an unlawful interpretation. 17 No court of law, however, has answered this question. 
II. Legal Prescriptions for Policy Proposals
The economic crisis and growing federal deficit may limit the prospect of congressional action on big-ticket items. Or, conversely, the dire economic situation might create an environment in which "deficits don't matter," thereby enabling the President and Congress to propose significant health reform legislation. No matter which congressional strategy the Obama Administration embraces, there are numerous ways the President can rely on his executive authority to create policies that help reshape federal programs and make improvements to the health care system. In addition, President Obama can invoke various administrative tools to lay the groundwork for future reform, much like Presidents Roosevelt, Truman, Kennedy, and Johnson did in the area of civil rights. 18 This section suggests ways that President Obama could use executive power to make health care policy without relying on Congress. The proposals below reflect some areas of common ground between the health care proposals offered by President Barack Obama and Senator John McCain during the presidential campaign, as well as the numerous legislative proposals currently being considered. This paper neither endorses nor condemns any of the policies; rather, it simply explains how the directives explained above may help the next President achieve some of his goals. The section ends by identifying policy proposals that would require enactment of legislation.
A. Expand Medicaid & SCHIP Coverage Through Section 1115 Waiver Authority
Nearly all of the current health reform proposals include some expansion of Medicaid and SCHIP. President Obama has discussed changing eligibility requirements, while Senator McCain suggested experimenting with Medicaid's payment scheme to allow greater coordinated care and alternative forms of access. Senators Ron Wyden and Robert Bennett have proposed converting Medicaid and SCHIP into supplemental insurance programs that would "wrap around" private coverage. 19 Senators Edward Kennedy and Max Baucus both have voiced strong support for instituting a variety of mechanisms to increase the number of children and adults covered.
One of the most significant sources of executive authority for testing these ideas on a large scale is section 1115 of the Social Security Act. 20 Congress enacted this provision to allow states to obtain waivers from the federal government to create demonstration projects that were limited in scope and short-term in nature. But the evolution of section 1115 illustrates how President Obama could use the waiver authority to allow significant flexibility in state Medicaid programs, including coverage expansions.
Section 1115 provides broad and general authority to the Secretary of the Department of Health and Human Services (HHS) to waive statutory and regulatory provisions without congressional approval or public notice. The executive branch has never issued regulations defining the standards or procedures that states must follow to win approval of proposed changes to the state programs. 21 Instead, HHS has used a variety of informal, non-binding methods to communicate procedures and rules for the program. HHS has, for example, published notices in the Federal Register; issued operations manuals; and disseminated department letters approving state programs, as well as letters to various state officials, researchers, and policymakers. For example, in September 1994, HHS published a public notice in the Federal Register announcing that the Clinton Administration would interpret section 1115 waiver authority broadly. 23 One of the most significant aspects of the public notice was its endorsement of demonstration programs that lasted longer than five years. This meant that the duration of an experimental project was no longer an important factor in determining whether it would win federal approval. 24 In addition, the costs of a demonstration project would be evaluated across the project's lifespan rather than on an annual basis. 25 Finally, the Administration allowed states to redirect monies from other parts of their Medicaid programs to demonstration projects.
After the Clinton Administration opened the door to massive changes in Medicaid through the section 1115 waiver program, the Bush Administration embarked on an era of significantly greater state flexibility. In August 2001, HHS Secretary Tommy Thompson announced the creation of the Health Insurance Flexibility and Accountability ("HIFA") initiative. 26 These waivers provide an expedited review process for states requesting waiver authority to loosen Medicaid requirements. In addition, HIFA's provisions help make waivers more widely available. 27 What started out as a fairly non-existent research and demonstration program in the 1960s has burgeoned into a shadow federal entitlement program. The Congressional Research Service (CRS) reports that as of January 2007, there have been 110 operational Medicaid and SCHIP waivers granted under section 1115. 28 In FY2005, federal spending on these waivers totaled $26.6 billion, accounting for nearly 15% of all federal Medicaid spending. 29 Even more surprising, nearly 14 million Americans receive Medicaid coverage through a section 1115 waiver program.
States are taking enormous advantage of the waiver process. The Obama Administration must decide whether it wishes to continue this approach. Some waiver programs have existed for more than fifteen years: states appear to re-apply and receive approval for the same program when nearing the expiration date. Numerous states have also created section 1115 waiver programs that apply statewide: many states provide comprehensive benefits through these programs instead of using them solely to test financing schemes or benefit packages. Several states have also used waivers to create "me, too" programs that are carbon copies of programs in other states. For example, a number of states have embraced the waiver program for providing family planning coverage.
In addition, the Obama Administration could allow states to continue using waivers to forgo some of the traditional requirements in Medicaid. States must ordinarily provide coverage to all those in a particular group who are eligible. 30 Medicaid unequivocally forbids enrollment caps, even when state budgets may not be able to cover everyone who is eligible. Despite this requirement, previous administrations have approved state waiver programs that cap the number of beneficiaries covered. Some states have also used waivers to create significant variation in the program design or benefits packages across the state, even though under the traditional Medicaid program these packages must be uniform for all participants. Many states are also providing different benefits packages to different groups of beneficiaries under the waiver programs, disregarding Medicaid's mandate that all persons eligible for health care coverage must receive a uniform benefits package. The evolution of section 1115 reveals the significant executive authority available to President Obama to make changes to Medicaid and SCHIP. There are numerous opportunities for the new Administration and Congress to experiment with many of the policy ideas that have been proposed recently, including expanding eligibility, changing benefits packages, trying new payment schemes, and encouraging coordinated care among physicians serving Medicaid beneficiaries.
B. Test Quality Initiatives Through Medicare Demonstration Authority
President Obama, John McCain, and a number of legislators have recommended changes to the Medicare program. Senator McCain, for example, suggested that Medicare modify its payment scheme to base provider compensation on diagnosis, prevention, and care coordination. He also proposed eliminating reimbursements for preventable medical errors and requiring disclosure of medical outcomes, quality of care, and costs. President Obama has discussed plans to base physician payment on performance, as well as to require the use of disease management programs to help those suffering from chronic conditions.
Medicare provides a significant source of executive authority for the President to determine whether these policies are worth pursuing on a larger scale. Little known and not often used, demonstration authority under the Medicare program would allow the Obama Administration to test new policies on a temporary basis. Section 222(a) of the Social Security Amendments of 1972 is the source of the executive's waiver authority. 32 The Centers for Medicare and Medicaid Services (CMS) may invoke this authority to "develop and engage in experiments and demonstration projects" to accomplish a variety of goals, including experimenting with new payment or reimbursement methods to increase program efficiency; testing policies that reduce Medicare spending; and trying new contracting methods with providers. 33 In so doing, the agency has extensive authority to forgo existing payment requirements for participants in the demonstration projects, thereby raising the possibility of increased Medicare spending. 34 In addition, the Secretary may waive compliance with other Medicare requirements as long as they relate to payment or reimbursement. 35 Despite this significant grant of demonstration authority, previous administrations have not invoked it often. Part of the reason may be that Congress usually authorizes the creation of Medicare demonstration projects, as it did with the Medicare Modernization Act of 2003, thereby limiting the need to rely solely on section 222 waivers. 36 Also, CMS has tended to invoke its section 222 authority most often to create capitated payment schemes in "Medicare/Medicaid integration projects for dual eligibles:" elderly and impoverished beneficiaries who receive benefits from both entitlement programs. 37 There are currently about fifty existing demonstration projects that have been authorized by section 222 waivers. 38 A review of these projects reveals that CMS is testing payment schemes to accomplish a variety of goals, including paying doctors for their success (i.e., performance) in satisfying clinical measures; 39 providing hospice services for beneficiaries living in rural areas; 40 expanding disease management and coordinated care; 41 many, if not all, of the Medicare policies that the President proposed during the campaign. In addition, Congress could pass legislation to encourage experimentation of quality and other programs pursuant to the President's section 222 power.
C. Expand Health Information Technology
Expanding the use of health information technology is a popular bipartisan policy that finds its way into most legislative reform proposals. The potential benefits are three-fold: using health IT could make the health care system more efficient, improve the quality of care delivered, and reduce costs in the long-run. 43 Policymakers must resolve numerous issues in designing and implementing health IT programs, including financing new computer systems, protecting patient privacy, and creating common computer "languages" and standardizing codes so numerous actors -doctors, hospitals, insurers, etc. -can exchange information effectively and efficiently. 44 This paper sets aside those difficult policy questions and addresses how the Obama Administration could use existing sources of authority to expand upon the existing policies. With numerous health IT programs already underway in the executive branch comes the likelihood for confusion and duplication of efforts. For example, at least eight agencies or organizations within HHS are currently involved in health IT efforts -including the American Health Information Community, the Office of the National Coordinator for Health Information Technology, the Federal Health Architecture, the Agency for Healthcare Research and Quality (which provides approximately $170 million in technology grants and contracts), the Health Resources and Services Administration, Indian Health Services, the National Institutes of Health, and the Centers for Medicaid and Medicare Services. This does not include separate electronic health record systems operated by the Department of Defense and the Veterans Health Administration, or the many private sector initiatives being led by insurers and other non-profit groups.
Even though the National Coordinator is partly responsible for coordinating executive branch efforts, his primary responsibility is to develop a national infrastructure so a majority of Americans have an electronic medical record by 2014. 45 Obtaining a comprehensive assessment of all the various efforts, therefore, is necessary to know where authority lies and how Congress can most effectively expand the President's power to significantly ramp up health IT efforts. The new administration could issue executive orders not only to direct agencies to complete a comprehensive review by a certain date, but also to help coordinate the activities of various agencies. 46 Additionally, as part of the Medicare physician payment legislation passed in July 2008, doctors may receive reimbursement increases for participating in an electronic prescribing program in Medicare Part D. 47 Even though the legislation sets the percentage increase in reimbursements, CMS has significant authority to fill out the details of the program within the confines of the statute. For example, CMS may determine the numerous rules that physicians must follow for how and what kind of data (i.e., drug type, benefits, potential chemical interactions, availability of alternatives) they should report --rules that will significantly impact the number of participants and overall success of the program. Although the Bush Administration has made progress in setting some of these standards pursuant to authority provided in the Medicare Modernization Act (MMA), 49 which created Medicare Part D, much more work is needed for implementing the new reimbursement program. 50 The Administrator also may provide hardship exceptions for providers who have difficulty satisfying the rules, including those in rural areas "without sufficient Internet access." 51 The new program, which was scheduled to begin on January 1, 2009, offers great opportunities for the new administration to experiment with e-prescribing policies until the fiveyear sunset in 2013. 52 Therefore, the physician reimbursement program is a source of significant authority to quickly expand the use of e-prescribing.
Finally, the new administration could rely on CMS's extensive demonstration authority in the Medicare program, as previously discussed, to experiment with reimbursement schemes that base payment on the quality of care provided (i.e., performance) and the use of technology. A recent demonstration project created by the Bush Administration provides a useful example. The Electronic Health Records Demonstration attempts to expand the use of electronic health records to help reduce both medical errors and costs. 53 CMS does not provide any up-front grants or payments to help physicians install the necessary programs. 54 Instead, the program pays primary care physicians who adopt electronic health records and then use them to provide data (which indicates performance) on a number of clinical quality measures, including for chronic conditions such as diabetes and heart disease. 55 There are three types of payments: an annual incentive payment lasting the duration of the fiveyear program; a payment after the second year for reporting the data; and a payment after each of the remaining years for performance. 56 The program uses existing measures endorsed by the National Quality Forum and used by health plans for years. 57 Such a program reflects the breadth of opportunities available to President Obama to test various policies before seeking congressional approval for health IT programs. ; therefore, the Obama administration will not be able to negotiate drug prices unless Congress amends section 1860D-11(i) of the MMA. However, the bill significantly expands the regulatory power of the HHS Secretary to implement the new drug benefit. Yet the Secretary has not taken full advantage of the congressional delegations of authority. Section 1121, in particular, gives the Secretary the power to allow U.S. licensed pharmacists and prescription drug wholesalers to re-import U.S. manufactured medications from Canada.
D. Promulgate Rules to
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The statute explicitly provides rulemaking authority to the Secretary to supply the details of the program without returning to Congress for additional grants of authority.
Before moving forward, however, HHS must satisfy some threshold safety measures, including certifying to Congress that the program "will pose no additional risk to the public's health and safety." imported drugs. Finally, the Department may provide waivers to individuals wishing to reimport drugs, although statistics reveal that millions of Americans already purchase drugs from other countries via the Internet. 62 Because the Bush Administration did not invoke section 1121 to create a Medicare drug re-importation program, President Obama will have an opportunity to tap into this significant source of congressionally delegated power to help reduce Medicare drug spending.
Certainly, the recent news about contaminated products from China give some pause regarding the assurance of safety in a Medicare drug re-importation program. However, section 1121 only allows re-importation from Canada and provides broad authority to the Secretary to set specific safety guidelines before allowing foreign-made drugs to enter U.S. borders. This "safety assurance" power is crucial for any steps the President wishes to take to place formal guidelines on the drugs that individuals are bringing across U.S. borders.
Another source of potential executive power is section 911 of the MMA.
63 Dubbed "Increased Flexibility in Medicare Administration," the statute grants the Department authority to enter into contracts with "providers of services, suppliers, and individuals" that administer the drug benefit.
64 Private insurers and other entities will serve as and largely replace the financial intermediaries that process the millions of claims they receive from providers each year.
The MMA's contracting language may provide the Obama Administration opportunities to invoke this authority to limit program costs. The legislative history notes that section 911 "would permit the Secretary to competitively contract with any eligible entity to serve as a Medicare Administrative Contractor (MAC)." 65 These new groups, operated by CMS, wield power to "mak[e] the payments" under Parts A and B of Medicare and to "determin[e] the amount of Medicare payments required to be made to providers and suppliers." 66 The legislative history also conveys Congress's blessing to allow the Secretary to develop measurements for evaluating the MACs' performance. Given the broad power delegated to CMS to negotiate contracts and rely on competitive bidding, opportunities exist for the agency to help keep Medicare spending down through free-market tools. It is important to note, however, that this power is limited. The MMA constrains the executive's authority such that the Secretary may not use the authority to change drug prices or the delivery system under Part D. 67 MACs must make payments pursuant to Title XVIII requirements. 68 Given the recent media attention regarding the amounts Medicare pays Durable Medical Equipment (DME) manufacturers, there is significant concern about how the new administration will continue to implement this contracting authority. As CMS finishes choosing and negotiating with DME MACs and the contractors for Parts A and B, the terms that CMS sets in these contracts at the early stages of the program will have an enormous impact on the level of costs savings it can generate.
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E. Enhance Patient Protections and Private Coverage Requirements
Both President Obama and Senator McCain offered campaign proposals to regulate the activities of the insurance industry. These proposals can be divided into two groups generally: 1) protecting patients' rights and 2) ensuring affordable, portable coverage with fewer restrictions. In the area of patients' rights, President Obama could invoke his executive authority to shape the Federal Employees Health Benefits Plan (FEHBP) by ordering federal agencies to adopt consumer protections in their health insurance policies. 70 President Clinton issued similar orders that directed the federal Office of Personnel Management (OPM) to punish insurers -possibly by terminating their contracts -when they did not comply with the requirements in his directives. 71 This order fulfilled two goals: it expanded patients' rights for federal employees, and it laid the groundwork for future legislation on managed care by creating a precedent of rules applicable to a large, privately-insured group. 72 The Senate made its most significant push for a Patients' Bill of Rights in 2001. Even though the bill ultimately was not enacted, Senator McCain joined with Senator Edward Kennedy to push legislation that demanded assurances of swift review and appeals processes for denial of coverage; added requirements on HMOs to remove barriers to specialty and emergency care; and provided enforcement mechanisms to ensure compliance by insurance companies. Despite its failure, opportunities remain for the Obama Administration to memorialize and apply many of these additional protections in the FEHBP through executive orders and memoranda. Given that approximately 8 million people participate in the program, creating these policies in the FEHBP would, at the very least, help policymakers understand what works before trying to enact these protections for the privately insured population at large.
The second source of executive authority originates with the Kennedy-Kassebaum legislation passed in 1996, also known as the Health Insurance Portability and Accountability Act (HIPAA). 73 This legislation enacted new portability and continuity of coverage requirements and requires insurers to offer individuals with pre-existing conditions the same access to benefits as the general public. It does not, however, set price limits or guarantee affordability.
HIPAA explicitly gave the President rulemaking authority to implement various parts of the bill. 74 The Clinton Administration invoked this power to issue an interim rule detailing the portability requirements and other obligations imposed on insurers. This rule covered a host of important policy issues, from defining the terms of enrollment to placing limitations on preexisting condition exclusions to determining when employers are not liable for treating employees' ailments. 75 The Departments of Treasury, Labor, and Health and Human Services continued to invite comments on the regulation until the end of the Clinton Administration, leaving it to the Bush Administration to finalize the guidelines pertaining to insurers. 76 On December 30, 2004, the three departments issued the final rule. 77 Comprising 81 pages in the Federal Register, HHS billed the changes as "regulations [that] essentially adopt the interim final rules issued by the three agencies in 1997, but include several significant modifications." 78 A review of the current rule reveals that much of the contents of the interim rule remained; for example, it emphasizes the "narrowness of permissible pre-existing condition exclusions." 79 Yet the current version made significant changes to the interim rule; for example, it allows insurers more latitude to impose a pre-existing condition exclusion for genetic illnesses. 80 In addition, the new rule changed the requirements for HMO affiliation periods -the time before HMO coverage becomes effective when a plan is not required to provide benefits. HMOs can apply differing affiliation periods as long as they do not violate the nondiscrimination provisions in HIPAA. The language in the rule is broad enough, however, to allow insurers to potentially restrict coverage arbitrarily among various beneficiaries. During the campaign, President Obama said that he would prohibit insurers from denying coverage based on pre-existing conditions. 81 The new administration may choose to reexamine the December 30, 2004, rule to determine whether it does enough to ensure continuous coverage and portability, and to limit the situations in which insurers may exclude coverage for those suffering from pre-existing conditions. Given the explicit rulemaking authority provided to the President in HIPAA, 82 President Obama also has the opportunity to create greater protections through additional regulations and possibly new executive directives for private plans that provide coverage for federal employees. The source of authority and its bounds are clear. The big question facing the Obama Administration is whether it wants to invoke this fairly broad power to create more rules for how the insurance industry operates.
F. Lift Agency Directives Restricting Coverage Under SCHIP and Medicaid
The Bush Administration has issued a number of regulations that reduce Medicaid spending. These new policies, among other things, allow higher premiums and co-payments for medical care; 83 eliminate funding for school-based outreach and enrollment programs; 84 cut federal funding for graduate medical education programs at teaching hospitals; 85 and limit the types of children's rehabilitative services (e.g., therapy for some developmental disabilities) that Medicaid will cover. 86 Even though Congress has enacted moratoria on the vast majority of these rules, they provide only a temporary suspension. The cost-sharing rule alone could reduce state and federal spending by $2.5 billion. 87 The Congressional Budget Office estimates that the rest of the regulations could eliminate more than $21 billion from the program, 88 much of which may be absorbed by state and local governments. 89 If the Obama Administration wishes to reconsider and possibly rescind these regulations, it could invoke its executive authority in a two-step process. First, President Obama could issue an executive order temporarily suspending or postponing action on regulations until further study of their impact. This would allow him time to determine whether previous rationales for the rules coincide with the his policy objectives -much like presidents since Ronald Reagan have doneand determine what modifications, if any, are necessary. 90 Second, HHS could change or permanently rescind the rules by promulgating new ones-but such a step would take time. HHS would need to follow the informal rulemaking requirements to ensure that no procedural deficiencies could open the new rules to legal challenge. Courts tend to be less deferential to agencies when reviewing regulatory changes created without a change in circumstances, as explained in Part III.A.3. Therefore, if the new administration chooses this approach, it should be careful to supply a reasoned analysis of why it believes the new agency interpretation is necessary.
Perhaps the most assertive recent invocation of executive power in the health care context is the Bush Administration's August 17, 2007, SCHIP directive. CMS issued the directive in the form of a letter to State Health Officials (SHO) limiting their discretion to set income eligibility caps for families whose kids participate in the Children's Health Insurance Program. 91 Before covering children in families earning above 250% of the federal poverty limit (FPL), states must 1) prove that they have covered at least 95% of children below 200% of the FPL; 2) ensure that private coverage of these children has not decreased by more than "two percentage points over the five-year period"; 92 3) require a twelve-month waiting period for children coming off private coverage; and 4) impose new cost-sharing requirements. 96 This memorandum represents one of the first instances of President Obama's using his executive authority to influence health policy.
G. Build On the Federal Employees Health Benefits Program
President Obama and Senator McCain both proposed policies for ensuring access to group coverage for those with pre-existing conditions who find it difficult to buy policies on the individual market. One option that has been mentioned as a potential springboard is the Federal Employees' Health Benefits Program (FEHBP). This popular program covers approximately 8 million people, including members of Congress, making it the largest employer-sponsored health insurance program in the country. 97 Beneficiaries may choose between fee-for-service plans and HMOs, with 70% opting for the former. 98 FFS policies are experience-rated, meaning that premiums are calculated based on "average service expenditures, administrative costs, and profits."
99 Unlike many other government programs, however, the statute governing FEHBP gives the Office of Personnel Management (OPM) enormous discretion to run the program.
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The statute grants OPM the power to negotiate benefits packages and premiums annually with plans. 101 In addition, OPM has the authority to suggest ways for plans to contain costs as they craft their proposals and premium requirements. 102 OPM has kept costs down compared to the other large purchasers 103 by using two mechanisms to compel competition among the dozens of participating insurers. First, the basic construct of FEHBP forces plans to compete with one another on the benefits offered. Even though OPM does not define a specific benefit package, it requires a core baseline of services that all plans must provide. Every plan, therefore, can build its own benefit package to cater to the population it hopes to attract. Second, the statute requires that premiums "reasonably and equitably" reflect the cost of the benefit packages provided through FEHBP. 104 The statute grants OPM the authority not only to adjust premiums, but also to place any remaining balances in the reserve funds when they prove too high. 105 One option for President Obama is to invoke executive orders and memoranda to memorialize many of OPM's practices. Because it operates more like a private employer than a public program, many of the cost-saving programs and other policies are not formally noted and available for public distribution. Especially given that OPM negotiates annually with plans, the shelf life for these ideas may be relatively short. President Obama could use executive tools to formalize many of these "best practices" for private insurers participating in other federal programs (i.e., Medicare, Medicaid, etc.). To ensure the broadest reach for these policies and to promote consistency across departments, the new administration should use directives such as executive orders or memoranda, rather than departmental letters.
Another question is how much the Obama Administration could experiment with expanding the FEHBP. During the campaign, the President proposed the creation of a new public plan, the National Health Insurance Exchange, through which small businesses and individuals could purchase insurance benefits similar to those offered in the FEHBP. 106 The statute provides no discretion to the OPM to replicate or open the program to populations beyond federal employees, their beneficiaries, and retirees. In order to allow others to participate in the program or a similar one, either by paying 100% of their own coverage or some other cost-sharing scheme, Congress would have to pass legislation. If the Obama Administration wishes to test a program that allows non-federal employees to participate, it would have to seek statutory authority even for a demonstration project that would apply to a limited group of people on a temporary basis. In 1999, for example, Congress passed legislation creating a 3-year demonstration project run jointly by the Department of Defense and OPM for Tricare beneficiaries. 107 Once the President receives the authority, the contracting and negotiating power in Chapter 89 provides enormous opportunity to test various policies, accumulate information about what works and what does not, and craft more thoughtful proposals for more permanent and broad-based changes.
H. Examples of Policies That Require Legislative Enactment
Even though a President has significant executive authority to make policy changes, his actions must adhere to the statutory language provided by Congress. Some of the health reform ideas proposed by President Obama and Senator McCain would require new legislation because the U.S. Code either does not provide the President the necessary authority, or it limits his discretion. This section identifies two areas that would require congressional action: tax proposals and selling insurance across state lines. It also reminds us that the President's authority to reform health care is not boundless.
The majority of health reform plans include some adjustment or revision of federal tax laws. Changing tax policies -by offering new tax credits, modifying the currently favorable treatment of employer-sponsored insurance, or eliminating various rules -would require legislative action. The Constitution places the power to lay taxes solely in the legislative branch. 108 Therefore, the President may not initiate changes to the tax structure, though he may obviously encourage Congress to do so.
During the campaign, Senator McCain offered a proposal to allow insurers to sell insurance across state lines in hopes of increasing competition and offering consumers greater choice. Such a move would require federal preemption legislation. States have been the traditional regulators of health insurance, as Congress explicitly recognized in 1945. 109 Even though most states have some similar basic standards, there is significant variation in many of their requirements, including access rules and types of benefits required. 110 Since the 1974 enactment of the Employee Retirement Income Security Act (ERISA), the federal government has become increasingly involved in regulating the benefits health insurance companies offer under employer-sponsored health plans. ERISA exempted private sector self-insured plans from state regulation. In addition, the Consolidated Omnibus Budget Reconciliation Act (COBRA) of 1986, and the Health Insurance Portability and Accountability Act (HIPAA) of 1996, provided additional consumer protections applicable to all private insurers. Despite this "floor" of federal rules, many insurance requirements still vary across states. Because insurers must comply with the laws of every state in which they operate, Congress would have to pass legislation explicitly preempting state regulatory authority. Specifically, federal legislation would be necessary to allow insurers to forgo some of the state rules so they could sell the same product across state lines.
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III. Limitations on Executive Authority
There are numerous ways to reform health care through the administrative process. Yet the bedrock system of checks and balances ensures that executive authority is not boundless. Even though the executive branch has grown in size, political aggressiveness, and policy impact, there are significant limitations on what President Obama can do without congressional approval.
Article II, Section 1 of the Constitution, the "Vesting Clause," is the starting point for understanding these constraints. It entrusts the authority to run the executive branch in one individual -the President. 112 Even though there is significant academic debate about how much power the President can exercise over the agencies (particularly the independent ones), 113 recent administrations have shown that the President ultimately controls the policy and political agenda for the executive branch. 114 In addition, the Constitution explicitly rests responsibility with the President for implementing Congress's legislative directives. Nevertheless, by dictating that the President "take Care that the Laws be faithfully executed," 115 the framers of the Constitution reminded the nation that the President's power to implement statutes is conditioned by the requirement that he or she adhere to Congress's intent as memorialized by the statutory language.
From stage right enters the judiciary. Courts play a critical role in making sure that the President does not overstep the interpretive power delegated by Congress and limited by the Constitution. The federal courts referee where Congress's directives end and the President's discretion begins. Indeed, during the last thirty years, the courts have imposed procedural and substantive constraints that limit the ability of agencies to disregard the will of Congress. It is often difficult, however, to reconcile legislative intent with the interpretive latitude provided to the President, particularly because Congress often does not clearly articulate its intentions. This tension has spawned thousands of pages of case law on the subject of judicial review.
This section explains and discusses these legal doctrines to help policymakers understand the limitations of reforming health care through the administrative process. It also analyzes the budgetary and political constraints on executive authority from both the legal and policy perspectives. Because history is often the best guide, Part III ends by providing statistics and examples of times when Congress has aggressively responded to the President's use of administrative tools.
A. Judicial Review of Administrative Tools
Chevron, Skidmore-Mead, State Farm, and Youngstown. These case names are commonplace among lawyers because they provide the legal boundaries that limit the executive branch's authority. These cases also are critically important to health policymakers so they can determine whether their proposals that rely not on Congress, but on administrative tools, encroach on the legislature's power to make law and on the judiciary's power to "say what the law is." 116 The goal of this section is to assess the state of the law for both the legal and non-legal audience in the health policy community.
Chevron: Statutory Interpretation
We start with the iconic administrative law case, Chevron, which courts use to evaluate the propriety of an agency's interpretation of statutes. Trumpeted as one of the most important public law cases of the twentieth century, the Chevron Court held that when legislative language is ambiguous, courts should defer to an agency's "reasonable" interpretations of the statutory text. 117 The Supreme Court provided a now famous two-step inquiry. First, courts should determine "whether Congress has directly spoken to the precise question at issue." 118 If, in other words, Congress's intent is unambiguously clear, then the agency must follow Congress's directive. If, on the other hand, Congress has not spoken directly to the precise question at issue (i.e., the statute is silent or ambiguous), it is for the federal courts to determine whether the agency's interpretation of the statute is reasonable. An agency's construction of a statute will stand -even if a court disagrees with it -as long as it is deemed reasonable. 119 The lesson for the Obama Administration is that it must be mindful of not veering too far from the statutory language when it implements provisions of the MMA and other laws.
The Supreme Court emphasized two reasons for its groundbreaking holding: agency expertise and political accountability. In explaining its decision, the Court signaled that presidential involvement in agency decision-making counseled for a strong form of deference:
While agencies are not directly accountable to the people, the Chief Executive is, and it is entirely appropriate for this political branch of the Government to make such policy choices-resolving the competing interests which Congress itself either inadvertently did not resolve, or intentionally left to be resolved by the agency charged with the administration of the statute in light of everyday realities. 120 
Skidmore-Mead: Sub-Regulatory Guidance
There are numerous situations, however, in which there is no indication that Congress intended to delegate authority to the executive branch to interpret the statute through regulations and other administrative tools that have the force of law.
121 Nevertheless, agencies often need to create policies, such as through sub-regulatory guidance as described in Part I, to flesh out the details of a program when notice and comment rulemaking is impractical. An example of such a situation is CMS's August 17, 2007, letter restricting SCHIP coverage, as discussed above. Agencies also can rely on these vehicles for implementing day-to-day decisions in Medicare, Medicaid, and other complex programs. The Supreme Court has held that in such circumstances, it will accord a relatively weaker standard of deference to the agency that is "proportional to [the agency's] power to persuade." 122 An agency must prove three things: first, that its interpretation is thorough, logical, and accords with expert views; second, that its interpretation follows from the agency's earlier interpretations of the statute; and third, that other sources of weight support the interpretation. 123 In short, under the Skidmore-Mead deference regime, the courts delve more deeply into the permissibility of an agency's interpretation of a statute than they do under Chevron. The Court recognized that the executive branch must often make decisions that Congress could not have foreseen, and that the agencies' expertise warrants some deference. 124 Nevertheless, questions remain about the level of deference certain forms of sub-regulatory guidance (e.g., publications on agency web pages) should receive. Time and litigation will eventually provide the answers.
State Farm: Regulatory Changes
The Supreme Court has indicated, however, that courts should look carefully at changes to existing regulations. "An agency's view of what is in the public interest may change, either with or without a change in circumstances. But an agency changing its course must supply a reasoned analysis." 125 Decided the same year as Chevron, the Court in State Farm communicated its frustration with the Reagan Administration's decision to rescind a safety rule for seatbelts despite the lack of change in external circumstances other than the election of a new president. Since then, the Supreme Court has acknowledged in a number of health care cases that courts should limit the deference provided to agency interpretations that conflict with previously-held views. 126 When a court reviews an agency's decision to revoke or modify a regulation, it applies the standard for reviewing challenges to new rules: a court may set aside a rule if it is "arbitrary and capricious."
127 Put more plainly, an agency must offer a rational explanation for its policy change and show that it accounted for the relevant facts and factors. 128 Even though the standard of review is the same for new and modified rules, satisfying this standard may be more difficult when the data on which the agency relied has not changed. As the Court explained:
Normally, an agency rule would be arbitrary and capricious if the agency has relied on factors which Congress has not intended it to consider, entirely failed to consider an important aspect of the problem, offered an explanation for its decision that runs counter to the evidence before the agency, or is so implausible that it could not be ascribed to a difference in view or the product of agency expertise. 129 State Farm review, therefore, is critically important for President Obama as he considers regulatory changes. If the new administration chooses to overturn some of President Bush's Medicaid or other regulations, it must anchor its explanation in data and facts that reveal a changed environment.
Youngstown: Executive Orders
Finally, a president often initiates policies through executive orders. One example is President Clinton's order requiring insurers to comply with patient protection requirements in the FEHBP. The Supreme Court has created a particular standard of judicial review for determining when an executive order has strayed beyond the President's authority. To help courts analyze the scope of presidential power, the Court provided a three-part framework. 131 First, if the President has acted pursuant to express or implied statutory authority, then his "authority is at its maximum" and is "supported by the strongest of presumptions and the widest latitude of judicial interpretation." 132 Second, if Congress has neither delegated nor denied authority to the President, then he must rely "upon his own independent powers, but there is a zone of twilight in which he and Congress may have concurrent authority, or in which its distribution is uncertain." 133 Finally, if the President's order contradicts Congress's "express or implied will," his authority is at its lowest ebb. 134 Courts will uphold an executive order in such circumstances only when the President's authority is based on a constitutional grant of exclusive power.
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B. Constraints Involving Appropriations
Appropriations constraints also may limit a president's authority to act unilaterally. The key question is how much latitude a president has to determine health care spending priorities once Congress has made the requisite appropriations. The President and agency officials are obligated to follow congressional directives in statutory text. But the executive branch usually makes the vast majority of spending decisions pursuant to lump-sum appropriations by Congress.
The Supreme Court provided clear guidance on this issue in Lincoln v. Vigil. The Court held that agency spending decisions of a lump-sum appropriation are unreviewable in court. 136 In laying out its rationale for the ruling, the Court emphasized the importance of permitting flexibility and deferring to agency expertise regarding the numerous policies and issues that must be balanced:
The allocation of funds from a lump-sum appropriation is [an] administrative decision traditionally regarded as committed to agency discretion. After all, the very point of a lump-sum appropriation is to give an agency the capacity to adapt to changing circumstances and meet its statutory responsibilities in what it sees as the most effective or desirable way. 137 The Supreme Court further noted that Congress could only use explicit statutory text to bind agencies to particular spending decisions. "[I]ndicia in committee reports and other legislative history as to how funds should or are expected to be spent do not establish any legal requirements on the agency." 138 Obviously, the President and his agency heads run political risks by ignoring legislative history and other indications by Congress that convey how it wishes the money to be spent. Refusing to follow these expressions, however, does not violate the law. President Obama will soon need to decide how he wishes his agencies to treat such legislative requests or suggestions. In early 2008, former President George W. Bush issued an executive order directing agencies not "to commit, obligate, or expend funds for any earmark" in a nonstatutory source. 139 In so doing, former President Bush took the discretionary principles of Lincoln v. Vigil one step further by ordering employees not to comply with earmark requests in legislative reports, letters from Members of Congress, or any other materials other than the explicit statutory text. 140 It is too early to tell what impact the executive order will have. One obvious consequence may be that Congress increases use of explicit funding restrictions in appropriations legislation, including those involving health care programs. The order goes against the longstanding tradition that agencies should at least consider congressional spending requests in committee reports and joint explanatory statements prepared by conference committees. 141 If President Obama retains the order, it is unlikely that a court will find it unlawful, particularly given the Supreme Court's significant deference in Lincoln to agency spending decisions.
C. Legislative Constraints: Congressional Review Act
The final question is how Congress can limit a President's executive authority to reform health care. The starting point is Congress's primary function -passing legislation. As discussed above, a significant source of the President's power comes from the authority that the legislative branch delegates through statutory text. Because Congress has increasingly delegated extensive power to flesh out the details of federal programs -which can be just as significant as the authorization itself -presidents have been able to take unilateral action much more often, particularly during the last thirty years. 142 Within this expanding sphere of power, presidents can utilize the many administrative tools available to shape policy.
But delegation is mostly a positive concept; it focuses on the power granted rather than limitations placed on authority. The flipside is the negative act. Specifically, how could Congress undo the President's use of executive authority? Congress may limit agencies' discretion through a number of processes, including appropriations bills. Perhaps the most significant tool available is the Congressional Review Act (CRA). 143 Enacted in 1996, the Act requires agencies to submit all rules to Congress before they can take effect. It allows Congress to pass a joint resolution disapproving of regulations issued by agencies, which the President must sign before the resolution takes effect. 144 The CRA also provides expedited procedures for Congress to consider and disapprove of rules. For most rules, Congress has 60 days from when it receives the rule to start the joint resolution process. 145 Once Congress enacts the resolution, "the agency may not reissue either that rule or any substantially similar one, except under authority of a subsequently enacted law." 146 The question then is: how often has Congress successfully reversed regulations and other directives by the executive branch? Congress has overturned only one rule under the CRA --a Clinton Administration ergonomics regulation in 2001. That should be unsurprising: garnering a two-thirds vote in each chamber to overturn a presidential directive (assuming the president has vetoed Congress's first attempt) is extraordinarily difficult. Anecdotal evidence reveals that legislators from 1940 to 1970 were equally unsuccessful at stopping Presidents' efforts to create policy unilaterally. www.oneillinstitute.org 21
Conclusion
As the Obama Administration crafts key policy and reform proposals for the coming years, health reform is a priority. The executive branch has the power to create, shape, and promote policy, including in health care. This authority is replete with legal issues steeped in both constitutional and statutory law, as well as the history of governing our nation. This paper describes ways that the President can work within constitutional and statutory boundaries to implement health reform.
While this paper does not purport to recommend particular uses of that executive authority, or to take a position on whether executive authority should be used expansively or sparingly, it analyzes the contours of the President's executive authority, and applies it to policy proposals identified by key players in the health reform debate. Specifically, this paper discusses administrative strategies to: (1) expand Medicaid and the State Children's Health Insurance Program (SCHIP) coverage through section 1115 waivers; (2) test quality initiatives through Medicare demonstration authority; (3) expand health information technology; (4) allow drug reimportation and experiment with contracting power under Medicare; (5) enhance patient protections and private coverage requirements; (6) lift coverage restrictions on Medicaid and SCHIP; and (7) build on the health insurance program for federal employees. While President Obama has already taken steps toward implementing his agenda, more options are available to achieve the Administration's policy goals.
